checkAd

     101  0 Kommentare Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations - Seite 2

    Additional findings include:

    • 94% of respondents find it helpful when healthcare providers post to social media and the vast majority (92%) say the content of these posts aligns with their understanding of IBS
    • Over 90% of IBS respondents find it informative when people post on social media about what they're going through; seeing posts about IBS helps to normalize it
    • 8 out of 10 respondents think their healthcare providers make them feel comfortable discussing their symptoms, however, 88% typically focus on talking about their primary symptom​
    • Approximately 8 out of 10 surveyed believe their healthcare providers make the best treatment choice for them, while about 2 out of 10 believe they do not
    • More specifically:
      • 96% of IBS-C/CIC respondents want their healthcare provider to understand all the symptoms they are experiencing rather than just the primary one
      • More than three-quarters of IBS-C/CIC patients report their current treatment is not meeting all treatment goals, citing the top 3 unresolved symptoms as bloating, abdominal discomfort and stomach pain
      • 95% of IBS-D respondents want their healthcare providers to ask about how their symptoms impact daily living
      • Roughly 3 in 4 IBS-D respondents report their current treatment was not meeting all treatment goals​ citing the top 2 unresolved symptoms as diarrhea and stomach pain

    ###

    About the Methodology
    The survey was conducted online in January 2024 in the U.S. by Fairleigh Dickinson University Polls on behalf of Salix Pharmaceuticals among 852 U.S. residents aged 18+, including 416 who have been diagnosed with IBS-C or CIC, and 436 who have been diagnosed with IBS-D. Respondents for this survey were selected from among those who have agreed to participate in our surveys. Respondents were compensated for their time up to $4.00. Due to the limitations of this survey, results may not be representative of everyone in the U.S. who have been diagnosed with IBS-C, CIC and/or IBS-D.

    About FDU Poll

    Since 2001, FDU Poll (a division of Fairleigh Dickinson University) has conducted survey research on issues of public importance. Utilizing best practices in survey methodology, the Poll produces research that is conducted nationally and statewide. Findings from FDU's surveys have been reported on numerous regional, national and international media outlets such as the New York Times, Washington Post, Wall Street Journal, Star-Ledger, as well as local and national broadcast media outlets. The FDU Poll is in the top tier of polls nationwide. Poll aggregator Five Thirty-Eight has released its new rankings of polls ranking FDU 31st in the country, out of more than 500.

    Seite 2 von 3


    Der Analyst erwartet ein Kursziel von 6,83$, was eine Steigerung von +4,95% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
    Übernehmen
    Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
    Bitte verändern Sie Kursziel, Zeitraum oder Emittent.
    Alternativ können Sie auch unsere Derivate-Suchen verwenden
    Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
    WerbungDisclaimer

    Diskutieren Sie über die enthaltenen Werte



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations - Seite 2 Salix Pharmaceuticals Releases Fourth Annual Patient Perspectives IBS Impact ReportLAVAL, QC / ACCESSWIRE / April 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), …

    Schreibe Deinen Kommentar

    Disclaimer